Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism S Boulkroun, F Beuschlein, GP Rossi, JF Golib-Dzib, E Fischer, L Amar, ... Hypertension 59 (3), 592-598, 2012 | 314 | 2012 |
A Meta-Analysis of Somatic KCNJ5 K+ Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma L Lenzini, G Rossitto, G Maiolino, C Letizia, JW Funder, GP Rossi The Journal of Clinical Endocrinology & Metabolism 100 (8), E1089-E1095, 2015 | 190 | 2015 |
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II A Semplicini, L Lenzini, M Sartori, I Papparella, LA Calò, E Pagnin, ... Journal of hypertension 24 (6), 1115-1124, 2006 | 155 | 2006 |
Primary hyperparathyroidism with concurrent primary aldosteronism C Maniero, A Fassina, V Guzzardo, L Lenzini, G Amadori, MR Pelizzo, ... Hypertension 58 (3), 341-346, 2011 | 103 | 2011 |
Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization G Rossitto, L Amar, M Azizi, A Riester, M Reincke, C Degenhart, ... The Journal of Clinical Endocrinology & Metabolism 105 (6), 2042-2052, 2020 | 93 | 2020 |
Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis L Lenzini, TM Seccia, E Aldighieri, AS Belloni, P Bernante, L Giuliani, ... Hypertension 50 (6), 1106-1113, 2007 | 83 | 2007 |
GPER-1 and estrogen receptor-β ligands modulate aldosterone synthesis B Caroccia, TM Seccia, AG Campos, F Gioco, M Kuppusamy, G Ceolotto, ... Endocrinology 155 (11), 4296-4304, 2014 | 68 | 2014 |
Lower Expression of the TWIK-Related Acid-Sensitive K+ Channel 2 (TASK-2) Gene Is a Hallmark of Aldosterone-Producing Adenoma Causing Human Primary … L Lenzini, B Caroccia, AG Campos, A Fassina, AS Belloni, TM Seccia, ... The Journal of Clinical Endocrinology & Metabolism 99 (4), E674-E682, 2014 | 67 | 2014 |
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium M Kuppusamy, B Caroccia, J Stindl, S Bandulik, L Lenzini, F Gioco, ... The Journal of Clinical Endocrinology & Metabolism 99 (9), E1765-E1773, 2014 | 66 | 2014 |
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Lp-PLA2 Studies Collaboration European Journal of Preventive Cardiology 14 (1), 3-11, 2007 | 62 | 2007 |
Genetic screening in arterial hypertension GP Rossi, G Ceolotto, B Caroccia, L Lenzini Nature Reviews Endocrinology 13 (5), 289-298, 2017 | 53 | 2017 |
Primary aldosteronism: the next five years JW Funder Hormone and Metabolic Research 49 (12), 977-983, 2017 | 46 | 2017 |
Adrenal venous sampling: cosyntropin stimulation or not? J Deinum, H Groenewoud, GJ Van Der Wilt, L Lenzini, GP Rossi European journal of endocrinology 181 (3), D15-D26, 2019 | 43 | 2019 |
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension G Rossitto, G Maiolino, S Lerco, G Ceolotto, G Blackburn, S Mary, ... Cardiovascular research 117 (5), 1372-1381, 2021 | 36 | 2021 |
Subtyping of primary aldosteronism with adrenal vein sampling: hormone-and side-specific effects of cosyntropin and metoclopramide G Rossitto, G Maiolino, L Lenzini, V Bisogni, TM Seccia, M Cesari, ... Surgery 163 (4), 789-795, 2018 | 33 | 2018 |
The molecular basis of primary aldosteronism: from chimeric gene to channelopathy L Lenzini, GP Rossi Current Opinion in Pharmacology 21, 35-42, 2015 | 33 | 2015 |
Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism L Giuliani, L Lenzini, M Antonello, E Aldighieri, AS Belloni, A Fassina, ... The Journal of Clinical Endocrinology & Metabolism 94 (2), 684-690, 2009 | 33 | 2009 |
Saga of familial hyperaldosteronism: yet a new channel L Lenzini, S Prisco, B Caroccia, GP Rossi Hypertension 71 (6), 1010-1014, 2018 | 32 | 2018 |
Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease G Maiolino, L Lenzini, L Pedon, M Cesari, TM Seccia, AC Frigo, ... Journal of Cardiovascular Medicine 16 (1), 29-36, 2015 | 31 | 2015 |
Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy E Iori, R Millioni, L Puricelli, G Arrigoni, L Lenzini, R Trevisan, P James, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1782 (11 …, 2008 | 31 | 2008 |